eCite Digital Repository

Association between erythropoietin gene polymorphisms and diabetic retinopathy

Citation

Abhary, S and Burdon, KP and Casson, RJ and Goggin, M and Petrovsky, NP and Craig, JE, Association between erythropoietin gene polymorphisms and diabetic retinopathy, Archives of Ophthalmology, 128, (1) pp. 102-106. ISSN 0003-9950 (2010) [Refereed Article]


Preview
PDF
Restricted - Request a copy
83Kb
  

Copyright Statement

Copyright 2010 American Medical Association

DOI: doi:10.1001/archophthalmol.2009.355

Abstract

Objective: To determine whether sequence variation in the erythropoietin gene (EPO) is associated with the development of diabetic retinopathy (DR). Methods: This was a multicenter study based on 518 subjects with long-standing diabetes mellitus (DM), 173 with type 1DM(T1DM) and 345 with type 2DM(T2DM). Study groups consisted of 233 control subjects with no DR, 155 subjects with nonproliferative DR, 126 with proliferative DR, and 90 with clinically significant macular edema. Subjects with end-stage renal disease were excluded. DNA extracted from blood of each subject was genotyped for 3 EPO single-nucleotide polymorphisms (SNPs). Results: All 3 SNPs in EPO were associated with overall DR status in the combined T1DM and T2DM and T2DM alone groups (CC genotype of rs507392, P<.008; GG genotype of rs1617640, P<.008; and CC genotype of rs551238, P<.008) in the multivariate analysis. The GCC haplotype was also associated with overall DR status in the combined DM and T2DM alone groups (P=.008) by multivariate analysis. All SNPs and the GCC haplotype were also associated with proliferative DR and clinically significant macular edema in the combinedDM andT2DMalone groups. No associations were found with T1DM alone. Conclusion: Sequence variation in EPO is associated with the risk of DR independent of duration of DM, degree of glycemic control, and nephropathy. Clinical Relevance: Identifying EPO genetic markers for high risk of developing DR could lead to the possibility of developing novel treatments or preventive therapies.

Item Details

Item Type:Refereed Article
Research Division:Medical and Health Sciences
Research Group:Ophthalmology and Optometry
Research Field:Ophthalmology
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Hearing, Vision, Speech and Their Disorders
Author:Burdon, KP (Associate Professor Kathryn Burdon)
ID Code:91098
Year Published:2010
Web of Science® Times Cited:25
Deposited By:Menzies Institute for Medical Research
Deposited On:2014-05-07
Last Modified:2014-08-04
Downloads:0

Repository Staff Only: item control page